Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.

Biotechnology

Manufacturing

Oxford Biomedica Solutions

Tim Kelly

Ryan Dickerson

Melissa P.

Kelly Quesada

Volker Glidden

Stephen Boyd

Marissa Stanvick

Diane Golebiowski

David Hamilton

Lori Karpes

Amy P.

Patricia Daggett

The Technical and Engineering team at Oxford Biomedica Solutions is responsible for optimizing and scaling the manufacturing processes for AAV and lentiviral-based cell and gene therapies. This team ensures the efficient and high-quality production of vectors by leveraging advanced engineering techniques and innovative technical solutions. Key roles include overseeing internal manufacturing operations, managing engineering projects, and maintaining the overall integrity and performance of the production systems to meet the evolving needs of pharmaceutical and biotechnology clients.

Technical and Engineering

Research and Development

Director Team

Quality Control and Assurance Team

Technical and Engineering

About

Team members

Other teams at Oxford Biomedica Solutions

Research and Development

Director Team

Quality Control and Assurance Team